Sun Pharma Completes Taro Merger
Acquisition
Taro Shareholders Approve Merger with Sun Pharma
Acquired-by
Taro Shareholders Approve Merger with Sun Pharma
Acquired-by
Taro Provides Results for Year Ended March 31, 2024
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Chemical Linked to Cancer Found in Acne Creams Including Proactiv, Clearasil
Customers
Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
AcquisitionInvestment
Taro Provides Results for December 31, 2023
India's Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 million
Acquisition
Taro Announces Merger Agreement with Sun Pharma
Acquisition
Taro Announces Merger Agreement with Sun Pharma
AcquisitionManagement Changes
Amicus (FOLD) Banks on Galafold, Overdependence a Concern
CustomersInvestment
Iovance (IOVA) Falls After Clinical Update on Lung Cancer Drug
Management Changes
Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis
CustomersPartnersInvestment
Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate
InvestmentPartners
Sanofi (SNY) Discontinues Tusamitamab Ravtansine Cancer Program
Management Changes
Taro Provides Results for September 30, 2023
Taro Provides Results for the Quarter Ended June 30, 2023
Customers
Krensavage Asset Management Opposes Sun's Lowball Bid for Taro
Acquisition
+ 21 more articles